Moreover, it is necessary to determine whether the radiosensitivity is also affected by the mutations of SMAD3 or SMAD4 in other cancers, such as nasopharyngeal carcinoma and lung cancer. This evidence concerns the gene SMAD4 and lung carcinoma.